MARATTO

article · International Journal of Immunopathology and Pharmacology

Clinical role of NDRG2-based methylation status on survival pattern of glioblastoma

20241 citationOpen accessAin Shams University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

Current findings highlight the importance of studying DNA methylation of NDRG2 as a key factor to understand the role of epigenetic alterations in GBM.

Research topics

  • Mechanisms of cancer metastasis
  • Epigenetics and DNA Methylation
  • Chromatin Remodeling and Cancer

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1177/03946320241250294

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.